시장조사 보고서 : 세계의 안구 건조증 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Dry Eye Syndrome Treatment Market Growth 2021-2026
	■ 상품코드 : LPI-2108K200007 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 133 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 안구 건조증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (액적, 젤, 물티슈, 안연고, 기타)와 용도별 시장규모 (병원, 클리닉, 가정용) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 안구 건조증 치료 시장 점유율
- 지역별 안구 건조증 치료 시장규모
- 주요지역의 종류별 시장규모 (액적, 젤, 물티슈, 안연고, 기타)
- 주요지역의 용도별 시장규모 (병원, 클리닉, 가정용)
- 미주의 안구 건조증 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 안구 건조증 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 안구 건조증 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 안구 건조증 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 안구 건조증 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Dry Eye Syndrome Treatment will have significant change from previous year. By the most conservative estimates of global Dry Eye Syndrome Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2992.9 million in 2019. Over the next five years the Dry Eye Syndrome Treatment market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 3477.5 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Syndrome Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Home

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Novartis
Allergan
Otsuka
Santen Pharmaceutical
Nicox
Auven Therapeutics
Akorn
Bausch & Lomb
Alimera
GlaxoSmithKline

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Eye Syndrome Treatment Consumption 2016-2026
2.1.2 Dry Eye Syndrome Treatment Consumption CAGR by Region
2.2 Dry Eye Syndrome Treatment Segment by Type
2.2.1 Liquid Drops
2.2.2 Gel
2.2.3 Liquid Wipes
2.2.4 Eye Ointment
2.2.5 Other
2.3 Dry Eye Syndrome Treatment Sales by Type
2.3.1 Global Dry Eye Syndrome Treatment Sales Market Share by Type (2016-2021)
2.3.2 Global Dry Eye Syndrome Treatment Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dry Eye Syndrome Treatment Sale Price by Type (2016-2021)
2.4 Dry Eye Syndrome Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Home
2.5 Dry Eye Syndrome Treatment Sales by Application
2.5.1 Global Dry Eye Syndrome Treatment Sale Market Share by Application (2016-2021)
2.5.2 Global Dry Eye Syndrome Treatment Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dry Eye Syndrome Treatment Sale Price by Application (2016-2021)

3 Global Dry Eye Syndrome Treatment by Company
3.1 Global Dry Eye Syndrome Treatment Sales Market Share by Company
3.1.1 Global Dry Eye Syndrome Treatment Sales by Company (2019-2021)
3.1.2 Global Dry Eye Syndrome Treatment Sales Market Share by Company (2019-2021)
3.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Company
3.2.1 Global Dry Eye Syndrome Treatment Revenue by Company (2019-2021)
3.2.2 Global Dry Eye Syndrome Treatment Revenue Market Share by Company (2019-2021)
3.3 Global Dry Eye Syndrome Treatment Sale Price by Company
3.4 Global Manufacturers Dry Eye Syndrome Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Eye Syndrome Treatment Product Location Distribution
3.4.2 Players Dry Eye Syndrome Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Dry Eye Syndrome Treatment by Region
4.1 Global Dry Eye Syndrome Treatment by Region
4.1.1 Global Dry Eye Syndrome Treatment Sales by Region
4.1.2 Global Dry Eye Syndrome Treatment Revenue by Region
4.2 Americas Dry Eye Syndrome Treatment Sales Growth
4.3 APAC Dry Eye Syndrome Treatment Sales Growth
4.4 Europe Dry Eye Syndrome Treatment Sales Growth
4.5 Middle East & Africa Dry Eye Syndrome Treatment Sales Growth

5 Americas
5.1 Americas Dry Eye Syndrome Treatment Sales by Country
5.1.1 Americas Dry Eye Syndrome Treatment Sales by Country (2016-2021)
5.1.2 Americas Dry Eye Syndrome Treatment Revenue by Country (2016-2021)
5.2 Americas Dry Eye Syndrome Treatment Sales by Type
5.3 Americas Dry Eye Syndrome Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Dry Eye Syndrome Treatment Sales by Region
6.1.1 APAC Dry Eye Syndrome Treatment Sales by Region (2016-2021)
6.1.2 APAC Dry Eye Syndrome Treatment Revenue by Region (2016-2021)
6.2 APAC Dry Eye Syndrome Treatment Sales by Type
6.3 APAC Dry Eye Syndrome Treatment Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Dry Eye Syndrome Treatment by Country
7.1.1 Europe Dry Eye Syndrome Treatment Sales by Country (2016-2021)
7.1.2 Europe Dry Eye Syndrome Treatment Revenue by Country (2016-2021)
7.2 Europe Dry Eye Syndrome Treatment Sales by Type
7.3 Europe Dry Eye Syndrome Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Dry Eye Syndrome Treatment by Country
8.1.1 Middle East & Africa Dry Eye Syndrome Treatment Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dry Eye Syndrome Treatment Revenue by Country (2016-2021)
8.2 Middle East & Africa Dry Eye Syndrome Treatment Sales by Type
8.3 Middle East & Africa Dry Eye Syndrome Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dry Eye Syndrome Treatment Distributors
10.3 Dry Eye Syndrome Treatment Customer

11 Global Dry Eye Syndrome Treatment Market Forecast
11.1 Global Dry Eye Syndrome Treatment Forecast by Region
11.1.1 Global Dry Eye Syndrome Treatment Forecast by Regions (2021-2026)
11.2.2 Global Dry Eye Syndrome Treatment Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Dry Eye Syndrome Treatment Forecast by Type
11.7 Global Dry Eye Syndrome Treatment Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Novartis Novartis Company Information
12.1.2 Novartis Dry Eye Syndrome Treatment Product Offered
12.1.3 Novartis Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novartis Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Dry Eye Syndrome Treatment Product Offered
12.2.3 Allergan Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Allergan Main Business Overview
12.2.5 Allergan Latest Developments
12.3 Otsuka
12.3.1 Otsuka Company Information
12.3.2 Otsuka Dry Eye Syndrome Treatment Product Offered
12.3.3 Otsuka Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Otsuka Main Business Overview
12.3.5 Otsuka Latest Developments
12.4 Santen Pharmaceutical
12.4.1 Santen Pharmaceutical Company Information
12.4.2 Santen Pharmaceutical Dry Eye Syndrome Treatment Product Offered
12.4.3 Santen Pharmaceutical Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Santen Pharmaceutical Main Business Overview
12.4.5 Santen Pharmaceutical Latest Developments
12.5 Nicox
12.5.1 Nicox Company Information
12.5.2 Nicox Dry Eye Syndrome Treatment Product Offered
12.5.3 Nicox Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Nicox Main Business Overview
12.5.5 Nicox Latest Developments
12.6 Auven Therapeutics
12.6.1 Auven Therapeutics Company Information
12.6.2 Auven Therapeutics Dry Eye Syndrome Treatment Product Offered
12.6.3 Auven Therapeutics Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Auven Therapeutics Main Business Overview
12.6.5 Auven Therapeutics Latest Developments
12.7 Akorn
12.7.1 Akorn Company Information
12.7.2 Akorn Dry Eye Syndrome Treatment Product Offered
12.7.3 Akorn Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Akorn Main Business Overview
12.7.5 Akorn Latest Developments
12.8 Bausch & Lomb
12.8.1 Bausch & Lomb Company Information
12.8.2 Bausch & Lomb Dry Eye Syndrome Treatment Product Offered
12.8.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Bausch & Lomb Main Business Overview
12.8.5 Bausch & Lomb Latest Developments
12.9 Alimera
12.9.1 Alimera Company Information
12.9.2 Alimera Dry Eye Syndrome Treatment Product Offered
12.9.3 Alimera Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Alimera Main Business Overview
12.9.5 Alimera Latest Developments
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Information
12.10.2 GlaxoSmithKline Dry Eye Syndrome Treatment Product Offered
12.10.3 GlaxoSmithKline Dry Eye Syndrome Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 GlaxoSmithKline Main Business Overview
12.10.5 GlaxoSmithKline Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Dry Eye Syndrome Treatment Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Liquid Drops
Table 3. Major Players of Gel
Table 4. Major Players of Liquid Wipes
Table 5. Major Players of Eye Ointment
Table 6. Major Players of Other
Table 7. Global Dry Eye Syndrome Treatment Sales by Type (2016-2021) & (K Units)
Table 8. Global Dry Eye Syndrome Treatment Sales Market Share by Type (2016-2021)
Table 9. Global Dry Eye Syndrome Treatment Revenue by Type (2016-2021) & ($ million)
Table 10. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 11. Global Dry Eye Syndrome Treatment Sale Price by Type (2016-2021)
Table 12. Global Dry Eye Syndrome Treatment Sales by Application (2016-2021) & (K Units)
Table 13. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2016-2021)
Table 14. Global Dry Eye Syndrome Treatment Value by Application (2016-2021)
Table 15. Global Dry Eye Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 16. Global Dry Eye Syndrome Treatment Sale Price by Application (2016-2021)
Table 17. Global Dry Eye Syndrome Treatment Sales by Company (2019-2021) & (K Units)
Table 18. Global Dry Eye Syndrome Treatment Sales Market Share by Company (2019-2021)
Table 19. Global Dry Eye Syndrome Treatment Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Dry Eye Syndrome Treatment Revenue Market Share by Company (2019-2021)
Table 21. Global Dry Eye Syndrome Treatment Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Dry Eye Syndrome Treatment Producing Area Distribution and Sales Area
Table 23. Players Dry Eye Syndrome Treatment Products Offered
Table 24. Dry Eye Syndrome Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Dry Eye Syndrome Treatment Sales by Region (2016-2021) (K Units)
Table 28. Global Dry Eye Syndrome Treatment Sales Market Share by Region (2016-2021)
Table 29. Global Dry Eye Syndrome Treatment Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Dry Eye Syndrome Treatment Revenue Market Share by Region (2016-2021)
Table 31. Americas Dry Eye Syndrome Treatment Sales by Country (2016-2021) & (K Units)
Table 32. Americas Dry Eye Syndrome Treatment Sales Market Share by Country (2016-2021)
Table 33. Americas Dry Eye Syndrome Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Dry Eye Syndrome Treatment Revenue Market Share by Country (2016-2021)
Table 35. Americas Dry Eye Syndrome Treatment Sales by Type (2016-2021) & (K Units)
Table 36. Americas Dry Eye Syndrome Treatment Sales Market Share by Type (2016-2021)
Table 37. Americas Dry Eye Syndrome Treatment Sales by Application (2016-2021) & (K Units)
Table 38. Americas Dry Eye Syndrome Treatment Sales Market Share by Application (2016-2021)
Table 39. APAC Dry Eye Syndrome Treatment Sales by Region (2016-2021) & (K Units)
Table 40. APAC Dry Eye Syndrome Treatment Sales Market Share by Region (2016-2021)
Table 41. APAC Dry Eye Syndrome Treatment Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Dry Eye Syndrome Treatment Revenue Market Share by Region (2016-2021)
Table 43. APAC Dry Eye Syndrome Treatment Sales by Type (2016-2021) & (K Units)
Table 44. APAC Dry Eye Syndrome Treatment Sales Market Share by Type (2016-2021)
Table 45. APAC Dry Eye Syndrome Treatment Sales by Application (2016-2021) & (K Units)
Table 46. APAC Dry Eye Syndrome Treatment Sales Market Share by Application (2016-2021)
Table 47. Europe Dry Eye Syndrome Treatment Sales by Country (2016-2021) & (K Units)
Table 48. Europe Dry Eye Syndrome Treatment Sales Market Share by Country (2016-2021)
Table 49. Europe Dry Eye Syndrome Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Dry Eye Syndrome Treatment Revenue Market Share by Country (2016-2021)
Table 51. Europe Dry Eye Syndrome Treatment Sales by Type (2016-2021) & (K Units)
Table 52. Europe Dry Eye Syndrome Treatment Sales Market Share by Type (2016-2021)
Table 53. Europe Dry Eye Syndrome Treatment Sales by Application (2016-2021) & (K Units)
Table 54. Europe Dry Eye Syndrome Treatment Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Dry Eye Syndrome Treatment Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Dry Eye Syndrome Treatment Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Dry Eye Syndrome Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Dry Eye Syndrome Treatment Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Dry Eye Syndrome Treatment Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Dry Eye Syndrome Treatment Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Dry Eye Syndrome Treatment Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Dry Eye Syndrome Treatment Sales Market Share by Application (2016-2021)
Table 63. Global Dry Eye Syndrome Treatment Sales Forecast by Type (2021-2026) & (K Units)
Table 64. Global Dry Eye Syndrome Treatment Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Dry Eye Syndrome Treatment Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Dry Eye Syndrome Treatment Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Dry Eye Syndrome Treatment Sales Forecast by Application (2021-2026) & (K Units)
Table 68. Global Dry Eye Syndrome Treatment Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Dry Eye Syndrome Treatment Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Dry Eye Syndrome Treatment Revenue Market Share Forecast by Application (2021-2026)
Table 71. Novartis Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 72. Novartis Dry Eye Syndrome Treatment Product Offered
Table 73. Novartis Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76. Allergan Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 77. Allergan Dry Eye Syndrome Treatment Product Offered
Table 78. Allergan Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 79. Allergan Main Business
Table 80. Allergan Latest Developments
Table 81. Otsuka Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 82. Otsuka Dry Eye Syndrome Treatment Product Offered
Table 83. Otsuka Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 84. Otsuka Main Business
Table 85. Otsuka Latest Developments
Table 86. Santen Pharmaceutical Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 87. Santen Pharmaceutical Dry Eye Syndrome Treatment Product Offered
Table 88. Santen Pharmaceutical Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Santen Pharmaceutical Main Business
Table 90. Santen Pharmaceutical Latest Developments
Table 91. Nicox Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 92. Nicox Dry Eye Syndrome Treatment Product Offered
Table 93. Nicox Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. Nicox Main Business
Table 95. Nicox Latest Developments
Table 96. Auven Therapeutics Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 97. Auven Therapeutics Dry Eye Syndrome Treatment Product Offered
Table 98. Auven Therapeutics Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Auven Therapeutics Main Business
Table 100. Auven Therapeutics Latest Developments
Table 101. Akorn Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 102. Akorn Dry Eye Syndrome Treatment Product Offered
Table 103. Akorn Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Akorn Main Business
Table 105. Akorn Latest Developments
Table 106. Bausch & Lomb Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 107. Bausch & Lomb Dry Eye Syndrome Treatment Product Offered
Table 108. Bausch & Lomb Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Bausch & Lomb Main Business
Table 110. Bausch & Lomb Latest Developments
Table 111. Alimera Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 112. Alimera Dry Eye Syndrome Treatment Product Offered
Table 113. Alimera Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Alimera Main Business
Table 115. Alimera Latest Developments
Table 116. GlaxoSmithKline Basic Information, Dry Eye Syndrome Treatment Manufacturing Base, Sales Area and Its Competitors
Table 117. GlaxoSmithKline Dry Eye Syndrome Treatment Product Offered
Table 118. GlaxoSmithKline Dry Eye Syndrome Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. GlaxoSmithKline Main Business
Table 120. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Dry Eye Syndrome Treatment
Figure 2. Dry Eye Syndrome Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Eye Syndrome Treatment Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Dry Eye Syndrome Treatment Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dry Eye Syndrome Treatment Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Liquid Drops
Figure 10. Product Picture of Gel
Figure 11. Product Picture of Liquid Wipes
Figure 12. Product Picture of Eye Ointment
Figure 13. Product Picture of Other
Figure 14. Global Dry Eye Syndrome Treatment Sales Market Share by Type in 2020
Figure 15. Global Dry Eye Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Dry Eye Syndrome Treatment Consumed in Hospital
Figure 17. Global Dry Eye Syndrome Treatment Market: Hospital (2016-2021) & (K Units)
Figure 18. Dry Eye Syndrome Treatment Consumed in Clinic
Figure 19. Global Dry Eye Syndrome Treatment Market: Clinic (2016-2021) & (K Units)
Figure 20. Dry Eye Syndrome Treatment Consumed in Home
Figure 21. Global Dry Eye Syndrome Treatment Market: Home (2016-2021) & (K Units)
Figure 22. Global Dry Eye Syndrome Treatment Sales Market Share by Application (2016-2021)
Figure 23. Global Dry Eye Syndrome Treatment Revenue Market Share by Application in 2020
Figure 24. Global Dry Eye Syndrome Treatment Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Dry Eye Syndrome Treatment Revenue Market Share by Company in 2020
Figure 26. Global Dry Eye Syndrome Treatment Sales Market Share by Regions (2016-2021)
Figure 27. Global Dry Eye Syndrome Treatment Revenue Market Share by Region in 2020
Figure 28. Americas Dry Eye Syndrome Treatment Sales 2016-2021 (K Units)
Figure 29. Americas Dry Eye Syndrome Treatment Revenue 2016-2021 ($ Millions)
Figure 30. APAC Dry Eye Syndrome Treatment Sales 2016-2021 (K Units)
Figure 31. APAC Dry Eye Syndrome Treatment Revenue 2016-2021 ($ Millions)
Figure 32. Europe Dry Eye Syndrome Treatment Sales 2016-2021 (K Units)
Figure 33. Europe Dry Eye Syndrome Treatment Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Dry Eye Syndrome Treatment Sales 2016-2021 (K Units)
Figure 35. Middle East & Africa Dry Eye Syndrome Treatment Revenue 2016-2021 ($ Millions)
Figure 36. Americas Dry Eye Syndrome Treatment Sales Market Share by Country in 2020
Figure 37. Americas Dry Eye Syndrome Treatment Revenue Market Share by Country in 2020
Figure 38. Americas Dry Eye Syndrome Treatment Sales Market Share by Type in 2020
Figure 39. Americas Dry Eye Syndrome Treatment Sales Market Share by Application in 2020
Figure 40. United States Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Dry Eye Syndrome Treatment Sales Market Share by Region in 2020
Figure 45. APAC Dry Eye Syndrome Treatment Revenue Market Share by Regions in 2020
Figure 46. APAC Dry Eye Syndrome Treatment Sales Market Share by Type in 2020
Figure 47. APAC Dry Eye Syndrome Treatment Sales Market Share by Application in 2020
Figure 48. China Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Dry Eye Syndrome Treatment Sales Market Share by Country in 2020
Figure 55. Europe Dry Eye Syndrome Treatment Revenue Market Share by Country in 2020
Figure 56. Europe Dry Eye Syndrome Treatment Sales Market Share by Type in 2020
Figure 57. Europe Dry Eye Syndrome Treatment Sales Market Share by Application in 2020
Figure 58. Germany Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Dry Eye Syndrome Treatment Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Dry Eye Syndrome Treatment Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Dry Eye Syndrome Treatment Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Dry Eye Syndrome Treatment Sales Market Share by Application in 2020
Figure 67. Egypt Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Dry Eye Syndrome Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles

※본 조사보고서 [세계의 안구 건조증 치료 시장예측 2021년-2026년] (코드 : LPI-2108K200007) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 안구 건조증 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 운동 선수용 무릎 치료 시장예측 2021년-2026년
LPI-2108K202110 / LP Information / 2021년 8월 / 본 조사보고서는 운동 선수용 무릎 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Athletic Knee Treatment will have significant change from previous year. By the most conservative estimates of global Athletic Knee Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 요실금 치료 장치 시장예측 2021년-2026년
LPI-2108K200081 / LP Information / 2021년 8월 / 본 조사보고서는 요실금 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Urinary Incontinence Treatment Devices will have significant change from previous year. By the most conservative estimates of global Urinary Incontinence Treatment Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1901.1...

세계의 양성 돌발성 체위성 현기증 (BPPV) 시장예측 2021년-2026년
LPI-2108K202113 / LP Information / 2021년 8월 / 본 조사보고서는 양성 돌발성 체위성 현기증 (BPPV)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Benign Positional Vertigo Treatment will have significant change from previous year. By the most conservative estimates of global Benign Positional Vertigo Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 간질 치료 장치 시장예측 2021년-2026년
LPI-2108K201335 / LP Information / 2021년 8월 / 본 조사보고서는 간질 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Epilepsy Treatment Device will have significant change from previous year. By the most conservative estimates of global Epilepsy Treatment Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 공기 처리 제품 시장예측 2021년-2026년
LPI-2108K202261 / LP Information / 2021년 8월 / 본 조사보고서는 공기 처리 제품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Air Treatment Products will have significant change from previous year. By the most conservative estimates of global Air Treatment Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 15320 million in...

세계의 유산소 치료 시스템 시장예측 2021년-2026년
LPI-2108K200494 / LP Information / 2021년 8월 / 본 조사보고서는 유산소 치료 시스템의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Aerobic Treatment Systems will have significant change from previous year. By the most conservative estimates of global Aerobic Treatment Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 치과용 유닛 시장예측 2021년-2026년
LPI-2108K200084 / LP Information / 2021년 8월 / 본 조사보고서는 치과용 유닛의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Dental Unit will have significant change from previous year. By the most conservative estimates of global Dental Unit market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 데메롤 (메페리딘) 시장예측 2021년-2026년
LPI-2108K201259 / LP Information / 2021년 8월 / 본 조사보고서는 데메롤 (메페리딘)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Demerol (Meperidine) will have significant change from previous year. By the most conservative estimates of global Demerol (Meperidine) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 정신 장애 치료약 시장예측 2021년-2026년
LPI-2108K201578 / LP Information / 2021년 8월 / 본 조사보고서는 정신 장애 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 인공 심폐기 시장예측 2021년-2026년
LPI-2108K201077 / LP Information / 2021년 8월 / 본 조사보고서는 인공 심폐기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Artificial Heart-Lung Machine will have significant change from previous year. By the most conservative estimates of global Artificial Heart-Lung Machine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 257.2 million in...